癌症患者对传统中医疗治疗的偏好:一个离散选择实验研究
Jiao Zhang1,2, Lihua Li1, Huinan Xi1
1School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.
BMC complementary medicine and therapies
|July 3, 2025
概括
癌症患者在选择传统中医 (TCM) 治疗时优先考虑疾病控制和生活质量. 患者的偏好显著影响了关于TCM疗程的决策,影响了健康促进策略.
科学领域:
- 在瘤学瘤学.
- 综合医学是一个整体的医学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 越来越多的人认识到传统中医 (TCM) 在癌症治疗中的有效性.
- 患者偏好在癌症治疗决策中的重要性越来越大.
- 需要了解患者对TCM的偏好,以加强临床决策.
研究的目的:
- 估计癌症患者对传统中医 (TCM) 治疗方案的具体偏好.
- 为瘤学中的临床决策和健康促进策略提供信息.
主要方法:
- 使用离散选择实验 (DCE) 方法的横截面研究.
- 通过假设的临床场景系统地诱导偏好.
- 使用混合逻辑模型进行分析,包括按性别分组分析.
主要成果:
- 728名参与者完成了这项研究.
- 影响TCM偏好的关键因素包括疾病控制率,不良反应,施用方式,治疗持续时间,生活质量和成本.
- 患者的偏好在不同性别群体中基本一致.
结论:
- 治疗属性显著影响癌症患者对TCM的偏好.
- 优先考虑疾病控制和生活质量对于癌症患者的TCM治疗决策至关重要.
更多相关视频
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
1.1K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.4K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
